Raphael Pharmaceutical Inc.
RAPH · OTCMCIK 1415397fmd_1SRXYXYWY1DRYF1S8F2SSJAQHGManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 25 periods
Latest annual · FY2025
Millions- Operating income
- (1)
- Net income
- (1)
Latest quarter · Q2 FY2026
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Raphael Pharmaceutical Inc. (RAPH) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.2 million | -$1.5 million | 10-K 2026-03-31 · proof | |
| Net income | -$1.3 million | -$1.5 million | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$210,000 | -$532,000 | 10-K 2026-03-31 · proof | |
| Total assets | $53,000 | $27,000 | +96.3% | 10-K 2026-03-31 · proof |
| Total liabilities | $1.5 million | $769,000 | +93.2% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $45,000 | $19,000 | +136.8% | 10-K 2026-03-31 · proof |
- What was Raphael Pharmaceutical Inc. (RAPH)'s operating income in fiscal 2025?
- Raphael Pharmaceutical Inc. (RAPH) reported operating income of -$1.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Raphael Pharmaceutical Inc. (RAPH)'s net income in fiscal 2025?
- Raphael Pharmaceutical Inc. (RAPH) reported net income of -$1.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Raphael Pharmaceutical Inc. (RAPH)'s cash from operating activities in fiscal 2025?
- Raphael Pharmaceutical Inc. (RAPH) reported cash from operating activities of -$210,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$532,000 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Raphael Pharmaceutical Inc. (RAPH)'s total assets?
- As of Dec 31, 2025, Raphael Pharmaceutical Inc. (RAPH) reported total assets of $53,000, against $27,000 a year earlier (+96.3%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Raphael Pharmaceutical Inc. (RAPH)'s total liabilities?
- As of Dec 31, 2025, Raphael Pharmaceutical Inc. (RAPH) reported total liabilities of $1.5 million, against $769,000 a year earlier (+93.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Raphael Pharmaceutical Inc. (RAPH)'s cash and cash equivalents?
- As of Dec 31, 2025, Raphael Pharmaceutical Inc. (RAPH) reported cash and cash equivalents of $45,000, against $19,000 a year earlier (+136.8%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:RAPH&period_type=annual&limit=5"Information only, not investment advice.